Phio Pharmaceuticals (PHIO) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free PHIO Stock Alerts $0.80 -0.04 (-4.78%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Phio Pharmaceuticals Short Interest DataCurrent Short Volume33,800 sharesPrevious Short Volume21,400 sharesChange Vs. Previous Month+57.94%Dollar Volume Sold Short$22,003.80Short Interest Ratio / Days to Cover0.1Last Record DateApril 15, 2024Outstanding Shares4,590,000 sharesFloat Size4,520,000 sharesShort Percent of Float0.75%Today's Trading Volume160,428 sharesAverage Trading Volume349,197 sharesToday's Volume Vs. Average46% Short Selling Phio Pharmaceuticals ? Sign up to receive the latest short interest report for Phio Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPHIO Short Interest Over TimePHIO Days to Cover Over TimePHIO Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Phio Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202433,800 shares $22,003.80 +57.9%0.8%0.1 $0.65 3/31/202421,400 shares $14,552.00 -87.9%0.5%0.1 $0.68 3/15/2024176,600 shares $167,593.40 +283.9%7.4%0.6 $0.95 2/29/202446,000 shares $49,680.00 -30.0%1.9%0.1 $1.08 2/15/202465,700 shares $42,705.00 +390.3%2.7%0.1 $0.65 1/31/202413,400 shares $7,959.60 -74.1%0.6%0 $0.59 Get the Latest News and Ratings for PHIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/202451,800 shares $35,700.56 -66.4%2.2%0.1 $0.69 12/31/2023154,200 shares $117,192.00 +23.8%6.4%0.1 $0.76 12/15/2023124,600 shares $94,696.00 +783.7%5.2%0.1 $0.76 11/30/202314,100 shares $15,418.35 -35.0%0.6%0 $1.09 11/15/202321,700 shares $22,568.00 -35.2%0.9%0 $1.04 10/31/202333,500 shares $41,540.00 -91.2%1.5%0 $1.24 10/15/2023379,900 shares $566,051.00 +1,920.7%17.4%0.4 $1.49 9/30/202318,800 shares $28,388.00 +8.7%0.9%0.8 $1.51 9/15/202317,300 shares $28,545.00 +17.7%0.8%0.6 $1.65 8/31/202314,700 shares $31,311.00 +19.5%0.7%0.5 $2.13 8/15/202312,300 shares $27,675.00 +2.5%0.6%0.2 $2.25 7/31/202312,000 shares $32,040.00 -60.0%0.8%0 $2.67 7/15/202330,000 shares $81,900.00 +18.1%2.0%0.1 $2.73 6/30/202325,400 shares $72,898.00 -71.9%1.7%0 $2.87 6/15/202390,300 shares $295,281.00 -12.6%6.1%0.2 $3.27 5/31/2023103,300 shares $361,550.00 +588.7%7.0%0.2 $3.50 5/15/202315,000 shares $50,550.00 -49.8%1.0%0 $3.37 4/30/202329,900 shares $101,062.00 +116.7%2.7%0.2 $3.38 4/15/202313,800 shares $70,816.08 -25.4%1.2%0.1 $5.13 3/31/202318,500 shares $103,970.00 -39.5%1.7%0.8 $5.62 3/15/202330,600 shares $174,132.36 -30.6%2.8%0.8 $5.69 2/28/202344,100 shares $241,668.00 +3.5%4.1%1.2 $5.48 2/15/202342,600 shares $221,520.00 +27.5%3.9%1.2 $5.20 1/31/202333,400 shares $207,808.12 -91.0%3.0%1.1 $6.22 1/15/2023370,600 shares $199,678.91 +305.9%2.8%1.4 $0.54 12/30/202291,300 shares $33,963.60 +157.2%0.7%0.4 $0.37 12/15/202235,500 shares $12,783.55 +7.3%0.3%0.3 $0.36 11/30/202233,100 shares $13,902.00 -14.7%0.3%0.5 $0.42 11/15/202238,800 shares $17,479.40 -38.1%0.3%0.5 $0.45 10/31/202262,700 shares $36,052.50 -35.6%0.5%0.8 $0.58 10/15/202297,300 shares $54,244.75 +19.2%0.7%1.1 $0.56 9/30/202281,600 shares $46,618.08 -6.5%0.6%0.9 $0.57 9/15/202287,300 shares $64,785.33 +46.7%0.7%0.8 $0.74 8/31/202259,500 shares $41,667.85 -31.6%0.4%0.5 $0.70The new financial threat that could wipe out millions… (Ad)During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video PHIO Short Interest - Frequently Asked Questions What is Phio Pharmaceuticals' current short interest? Short interest is the volume of Phio Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 33,800 shares of PHIO short. 0.75% of Phio Pharmaceuticals' shares are currently sold short. Learn More on Phio Pharmaceuticals' current short interest. What is a good short interest percentage for Phio Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.75% of Phio Pharmaceuticals' floating shares are currently sold short. Is Phio Pharmaceuticals' short interest increasing or decreasing? Phio Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 33,800 shares, an increase of 57.9% from the previous total of 21,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Phio Pharmaceuticals' float size? Phio Pharmaceuticals currently has issued a total of 4,590,000 shares. Some of Phio Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Phio Pharmaceuticals currently has a public float of 4,520,000 shares. How does Phio Pharmaceuticals' short interest compare to its competitors? 0.75% of Phio Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Phio Pharmaceuticals: Alzamend Neuro, Inc. (0.30%), Revelation Biosciences, Inc. (1.13%), GeoVax Labs, Inc. (0.28%), Evoke Pharma, Inc. (0.54%), Atreca, Inc. (0.37%), Artelo Biosciences, Inc. (0.19%), Clever Leaves Holdings Inc. (0.61%), Ensysce Biosciences, Inc. (0.14%), Longeveron Inc. (9.34%), Soligenix, Inc. (8.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Phio Pharmaceuticals stock? Short selling PHIO is an investing strategy that aims to generate trading profit from Phio Pharmaceuticals as its price is falling. PHIO shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Phio Pharmaceuticals? A short squeeze for Phio Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PHIO, which in turn drives the price of the stock up even further. How often is Phio Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Alzamend Neuro Short Squeeze Revelation Biosciences Short Squeeze GeoVax Labs Short Squeeze Evoke Pharma Short Squeeze Atreca Short Squeeze Artelo Biosciences Short Squeeze Clever Leaves Short Squeeze Ensysce Biosciences Short Squeeze Longeveron Short Squeeze Soligenix Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PHIO) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsHe Is Giving Away BitcoinCrypto Swap Profits